/
/
Can The "More" Treatment Approach Cure Myeloma?
Can The "More" Treatment Approach Cure Myeloma? image
Can The "More" Treatment Approach Cure Myeloma?
Posted Nov 10, 2014

Here's one radio program you won't want to miss! Cure Panel interviews Dr. Gareth Morgan from top myeloma treatment facility University of Arkansas Medical Center (UAMS) on Tuesday, November 18 at 5PM Eastern Standard Time. The "Total Therapy" protocol for myeloma patients was developed at UAMS and the facility boasts some of the best myeloma survival rates in the world. On this show, Dr. Morgan will approach the "More Can Cure" approach, which has, and will continue to, be a very hot topic in the myeloma community. According to patient advocate and myeloma survivor himself, Gary Petersen, he writes on his blog. Myeloma Survival (www.myelomasurvival.com), many questions come to mind for this program, like:

  • How will UAMS' program change under the new leadership of Dr. Morgan?
  • UAMS has conducted clinical trials, however, they were usually UAMS-specific trials only. Will UAMS continue this strategy or will they be involved in the new monoclonal antibody clinical trials?

Mark your calendar and be sure to participate in this radio program. To pre-submit questions, email them to Priya@trialx.com. To listen in on the program, simply dial 718.664.6574 from the USA during show time or visit the Cure Talk Channel on BlogTalk Radio.

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

More Myeloma News Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811